Therefore, a multi-marker approach including u-actin and the measurement of various damage biomarkers (e.g. urine Cystatin C, KIM-1, NGAL, IL-18) may provide valuable information regarding the more accurate staging of sepsis-related AKI. The gene discussed is HAVCR1; the disease is acute kidney injury.